Biotage Moves into the Black as Q3 Revenues Rise 6 Percent | GenomeWeb
NEW YORK (GenomeWeb News) - Swedish life sciences technology firm Biotage posted a 6 percent increase in third-quarter revenues yesterday, as a loss in the prior-year quarter swung into a profit.
 
Sales for the quarter ended Sept. 30 rose to SEK 133.9 million ($18 million) from SEK 126.6 million ($17.3 million) in the third quarter of 2005.
 
Revenues for the firm’s discovery chemistry business increased 7 percent, to SEK 111.5 million, while biosystems revenues were relatively flat at SEK 22.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.